Eagle Pharmaceuticals
EGRX
₹85.60
Share price
0.00%
Change (1 day)
-79.80%
Change (1 year)
Categories
P/S ratio for Eagle Pharmaceuticals (EGRX)
P/S ratio as of March 2025 (TTM): 0.0503
According to Eagle Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.0514. At the end of 2023 the company had a P/S ratio of 0.9881.
P/S ratio history for Eagle Pharmaceuticals from 2014 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.9881 | -17.77% |
| 2022 | 1.20 | -68.65% |
| 2021 | 3.83 | 18.63% |
| 2020 | 3.23 | -22.71% |
| 2019 | 4.18 | 59.07% |
| 2018 | 2.63 | -21.96% |
| 2017 | 3.37 | -48.03% |
| 2016 | 6.48 | -69.05% |
| 2015 | 20.9 | 84.82% |
| 2014 | 11.3 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 4.39 | 8,629.71% | 🇺🇸 USA |
 | 1.94 | 3,759.33% | 🇬🇧 UK |
 | 4.22 | 8,279.71% | 🇨🇭 Switzerland |
 | 1.09 | 2,066.73% | 🇮🇱 Israel |
 | 4.92 | 9,670.64% | 🇺🇸 USA |
 | 16.5 | 32,754.66% | 🇺🇸 USA |
 | 2.48 | 4,831.90% | 🇺🇸 USA |